Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent News there Chart...
BOOM!!! 50 day MA uptick today!!! That's the definition of uptrend, and today's the first day, see the chart, many trading systems issue buy signals when the 50 day MA turns higher and today we got it!!! $RXMD
Thanks for all the glowing progressive updates Serb...
Reported record-breaking year-over-year sales and growth numbers
In Q2 2018, the Company reported a total of $10.3 million in revenue, the largest single six-month period in its history to date. Progressive Care also experienced increases in prescriptions filled, reporting a 21.45% increase compared to the same quarter in 2017. Progressive Care's pharmacy services revenue growth is a result of the Company's expanding breadth of services, manufacturer price increases, new drugs coming to market, new indications for existing drugs, volume growth with current clients, and addition of new customers due to its focus on higher patient engagement and clinical expertise.
The Company dispensed a total of 66,800 prescriptions in Q2 2018, a 21.45% increase over Q2 2017. Progressive Care's total assets were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017 an increase of 43.13%.
Furthered growth and expansion plans through pharmacy acquisition
The Company executed a definitive agreement to purchase the Touchpoint Rx pharmacy in Palm Beach County. Under this agreement, PharmCo assumed all day-to-day management of the pharmacy, which included assumption of all revenue and expenses. The acquisition will facilitate the Company's growth plans by decreasing the cost of servicing its delivery radius into Martin County, which includes Jupiter and Stuart, and will decrease costs of expansion and increase prescription dispensing efficiency.
RXMD... The one you keep...
The Best is yet to Be...
NEWS - RXMD reports largest 6 month revenue period in company history...
"Total Assets for the company were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017, an increase of 43.13%." [Strong Buy - Target = .35]
Buying in the 8's...
Back to the 8's by eod...
Why would anyone buy just 160 shares..?
Games will end soon enough...
Standing by...
Right you are...
Shorts covering by end of day... Then a new Green Wave starts for RNVA...
MM's are so scared if RNVA cross 0.0010, because of their naked shorts, they are thinking about 10Q to be release today or tomorrow, they will start buying hugely at 3:00 pm
Multiple Green waves ahead for RXMD...
It's all in the name: "Progressive..."
Getting rid of the Chicago Ventures debt makes this extremely attractive especially at this price. I am very interested in hearing the conference call and earnings report along with forward guidance.
Would sure love to see us operating in the black - that would be sensational news - that day is coming! With the second store gaining traction and revenues coming in our numbers should be getting better and better every day. Let's go!
Tomorrows Conference call going to be a goody...
Will start next green wave for RXMD and never look back...
8>>>>>>>>>>>9>>>>>>>>12>>>>>>>>>>>>26
If they're true to their word and file on time tomorrow 081418 that would represent a very optimistic turnaround with our new CFO... I believe she will deliver commencing the next green wave for RNVA...
We look forward to a significant improvement in the revenues and performance in Rennova in the coming quarters,” said Marlene McLennan, the recently appointed CFO of Rennova. “We expect to file our second quarter financial report to June 30 on time by August 14 and are making every effort to have it completed and filed earlier if possible”.
Well... I believe in miracles...
Everyone who knows RXMD will be going back to 26 soon enough...
I agree... Thanks Mickey...
Yep... You got that right my friend...
Bought in Friday cuz chart shows breaking above the 50 day MA, first time since April here, .20-.25 target.....everything Pharma, Biotech, and all things health care are bottoming now, lots of op with many health care plays on Ihub now!!! $RXMD is just one! (and the best...)
Ready... Set... Go: 9>>>> 10 >>>> 12 >>>> 265
Many of the short positions already got burned out on Friday...
The rest will be burned away this coming week.
These are the golden days for RXMD...
Sounds like you're back on track there John...
The Breakout is On in Progressive Care Inc
By James Hudson - August 12, 2018
OracleDispatch.com
One stock that had been a massive outperformer earlier this year, but has corrected back to a test of its 200-day simple moving average is Progressive Care Inc (OTCMKTS:RXMD). The pop to close out last week broke solidly back above the major MA’s and recent range resistance, helped along by the company’s announcement that it has paid off its convertible note to Chicago Venture Partners through an issuance of common stock.
According to the company’s most recent release, “Progressive Care drew down a tranche against the Chicago Venture note in the amount of $636,304 on February 15, 2018. The issuance of 1,974,279 shares of Progressive Care stock on August 8, 2018, brings the company to a balance of zero and the total number of issued shares to 15,503,604. The company has been working to pay down its liabilities while continuing to increase revenues and bring increased value to its shareholders.”
Progressive Care Inc (OTCMKTS:RXMD), through its subsidiary Pharmco LLC, trumpets itself as a company that provides prescription pharmaceuticals to individuals and institutions in South Florida.
The company operates a retail pharmacy that specializes in the sale of anti-retroviral medications and related patient care management; the sale and rental of durable medical equipment (DME), such as hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories; and the supply of various prescription medications to long-term care facilities.
It also provides long-term care solutions to skilled nursing facilities, assisted living facilities, retirement centers and communities, doctors’ offices, and clinics. In addition, the company purchases, repackages, and dispenses prescription and non-prescription pharmaceutical products for its long-term care customers.
Further, it offers computerized maintenance of patient prescription histories; third-party billing; and consultant pharmacist services consisting of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system, as well as home service and maintenance, defective product replacements, and free home installation and instruction services.
According to company materials, “Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.”
As noted above, the stock has been consolidating for months but caught some big air to close out last week. Recent action has seen 46% piled on for shareholders of the name during the trailing week. In addition, the company has seen interest climb, with an increase in recent trading volume of 71% beyond its prior sustained average level.
“We have a long-standing relationship with Chicago Venture Partners and they have played an instrumental role in allowing Progressive Care to move forward with its expansion plans,” said S. Parikh Mars, CEO of Progressive Care. “Being able to pay off this convertible note is an exciting milestone for the company, as we can now shift our entire focus to accelerating our expansion plans.”
Note that the company will be reporting earnings next week and on call to discuss results on Tuesday, Aug. 14, 2018, at 4:30 pm ET. According to its release, there should also be some discussion by management on the call of its outlook and objectives.
Currently trading at a market capitalization of $35.8M, RXMD has a stash ($1.3M) of cash on the books, which is balanced by about $385K in total current liabilities. One should also note that debt has been growing over recent quarters.(???) RXMD is pulling in trailing 12-month revenues of $20.4M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 6.2%. You can bet we will update this one again as new information comes into view.
Disclosure: we hold no position in $RXMD, either long or short, and we have not been compensated for this article.
Right you are friend...
Better buy Monday morning at open once it breaks 10 cents its gone...
Yep... Like 9+
A lot of stuff going on off the board and a lot of talk about RXMD. Expect something big next week.
I suppose we'll see how the flip game ends soon...
Yep... Something good in the works here...
Come on RNVA! Move up your ask to .0011! Lets get it over .0010 before the end of the day!!! Keeps creeping up!!! Let's do it! Earnings must be good... someone is buying higher!! Lets go!
Where did everybody go..?
Strange trading today...
RXMD will break HOD before the close...
We shall see...
Why the sudden increase in pps..?
What changed..?
And so it begins...
.06>>>>>> .07 >>>>>>>> .265
If all the longs hit the ask at these Levels. We would increase the value of our holdings, take the shorts out and kill manipulation.
Makes alot of sense my friend...
Remember there are 27 strategic buyers out there and we just need 1 good bid from a billion dollar company.. as you know the future is going to be bio based chemicals .. I highly doubt you don’t have a single bid from strategic buyers.. JMHO
As usual... You are no help to any investors here...
Yep... Gonna be a good one..!
July's REVENUE numbers with new location coming soon, likely next week.
Greetings Sub...
You seem to be quite knowledgeable about what's happening here...
Do you have any clue as to pps direction in the next days up through the 15th..?
Bottom line... Assets exceed liabilities...
Thanks Penman...
I'm still hanging in there...
Tomorrow could start a green wave...
Yep....
RXMD >>>>>>>>>>>>>> .06-.07 >>>>>>>>>>>>>> .2659
It's a commin...
That is my question also...
Is Eno still at BioAmber..?
Anyone know..?
So... we could actually get another update tomorrow...
One way from here... UP...
Expect any good news in the week(s) to come my friend..?
Who is they..?
And where are they getting the shares..?
So you're saying you believe the spike point is.008 then..?
YES I did a video about the Corn Prices and OIL.. NOW if you look at corn prices stability over the last 35 years 150$ is the avg price and many years farmers lost money and needed to be subsedized by government aid...
NOW a question has any one asked PWC a ball park figure on how much they would like to get..START UP INTO A TURN KEY IS with Tangebles intangebles 400 million
REG SHO
2018 08 07|BIOAQ| 907 535|0|10 163 066|O 10%
2018 08 08|BIOAQ| 4 329 034|0|13 986 529|O 30%
AVG price.....01 now to cover the need .008 ...thats when I assume am hoping they spike it.. so how many NK do they hold...I assume about ?? it was up to .011 down to .095 total possible profit 6000$.
Why do folks keep referencing Eno..?
I've heard numerous times from multiple posters that Eno's not in the picture anymore. Is this not in itself good news..?
Excellent report... Thank you my friend...
We will not see in 2nd quarter numbers, but I do have a feeling that we may come close or break the $2 million month revenue number when July 2018 revenues are reported next week. We'll see.
By the end of the year though, we will see a significant income boost in my opinion. As 340B contracts start Oct 1, 2018 and the Westchester General Hospital partnership gets up and rbringingbrining in more scripts and revenues for Pharmco. To be honest right now I have projected 280,000 scripts with one location, I think with 2nd location we easily exceed 300,000 scripts before the end of the year. Which will be over a 33% increase from the previous 5 years by:
2017 = 224,500 for a 33% increase
2016 = 213,400 for a 41% increase
2015 = 180,000 for a 67% increase
2014 = 140,000 for a 114% increase
2013 = 105,000 for a 186% increase
Net revenues would be doing the same if not for reimbursement changes currently affecting healthcare.
Thanks Jimmy...
Do you believe we'll see a significant income boost from the 2nd location on 081518..?
BUSINESS IS GOOD
Industry average was 60,000 scripts per location. Lol. RXMD is expected to exceed 280,000 this year with just the 1 location. That's over 450% greater than the industry average. They are churning out some major business especially when you consider scripts this year will increase by 50,000 alone, which is nearly equal to the industry average.
http://www.ncpa.co/pdf/digest/2016/2016-ncpa-digest-spon-cardinal.pdf
RXMD Gross Profit Margins are still above the previous years industry average for 1st Qtr with 22.9%. RXMD Gross Profit Margins for 2017 exceeded the industry average by nearly 5%. Seems like they are performing just fine considering all pharmacies and healthcare in general are undergoing the reimbursement pullbacks.
NEWSFLASH: 2ND LOCATION ACQUIRED JULY 1, 2018.
Right you are my friend..!
What is going on with the PPS should really have nothing to do with the final out come... ZILTCH is just like a penny 100 000 shares is 1000$ for those who cant afford it, its a gold mine to sell.. But for those who know this is 30 to one plus well worth the gamble... 30 to one is 3000%
Anyone else heard about this..?
I see BIOAQ earnings expected to be released 12:00am August 7th...